Cargando…

Value of Carbohydrate Antigen 19-9 in Predicting Response and Therapy Control in Patients with Metastatic Pancreatic Cancer Undergoing First-Line Therapy

Background: Serum carbohydrate antigen 19-9 (CA 19-9) has been shown to be a sensitive and specific serum marker for pancreatic cancer. Little has been published about correlations between baseline CA 19-9 level or changes to CA 19-9 level and median overall survival (mOS). Its impact on monitoring...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pelzer, Uwe, Hilbig, Andreas, Sinn, Marianne, Stieler, Jens, Bahra, Marcus, Dörken, Bernd, Riess, Hanno
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682131/ https://www.ncbi.nlm.nih.gov/pubmed/23785668 http://dx.doi.org/10.3389/fonc.2013.00155

Ejemplares similares

Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer – the CONKO 004 pilot trial
por: Pelzer, Uwe, et al.
Publicado: (2014)

Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy)
por: Riess, Hanno, et al.
Publicado: (2008)

α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study
por: Sinn, M, et al.
Publicado: (2014)

Blood group determinates incidence for pancreatic cancer in Germany
por: Pelzer, U., et al.
Publicado: (2013)

Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study
por: Pelzer, Uwe, et al.
Publicado: (2010)

Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients
por: Zschaeck, Sebastian, et al.
Publicado: (2017)

Intensity-Modulated and Image-Guided Radiotherapy in Patients with Locally Advanced Inoperable Pancreatic Cancer after Preradiation Chemotherapy
por: Sinn, M., et al.
Publicado: (2014)

Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study
por: Striefler, Jana Käthe, et al.
Publicado: (2021)

Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer—The CONKO-008 Phase I Investigation
por: Striefler, Jana K., et al.
Publicado: (2022)

Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with primary liver cancer: A phase II-study (NCT00356161)
por: Sinn, Marianne, et al.
Publicado: (2013)

Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma
por: Lohneis, Philipp, et al.
Publicado: (2018)

Clinical Lessons to Be Learned from Patients Developing Chronic Myeloid Leukemia While on Immunosuppressive Therapy after Solid Organ Transplantation: Yet Another Case after Orthotopic Heart Transplantation
por: Oberender, Christian, et al.
Publicado: (2014)

Induction Chemotherapy for Primarily Unresectable Locally Advanced Pancreatic Adenocarcinoma—Who Will Benefit from a Secondary Resection?
por: Rosumeck, Nathalie, et al.
Publicado: (2021)

Genetic dissection of apoptosis and cell cycle control in response of colorectal cancer treated with preoperative radiochemotherapy
por: Sturm, Isrid, et al.
Publicado: (2006)

Diagnostic and Prognostic Performance of MicroRNA-25, Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, and Carbohydrate Antigen 125 in Pancreatic Ductal Adenocarcinoma
por: Gong, Yan, et al.
Publicado: (2023)

Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with colorectal liver metastases: A phase II-study and historical comparison with the surgical approach
por: Hildebrandt, Bert, et al.
Publicado: (2007)

Systemic Therapy for Metastatic Pancreatic Cancer
por: Ettrich, Thomas J., et al.
Publicado: (2021)

Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies?
por: Felsenstein, Matthäus, et al.
Publicado: (2022)

CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
por: Noll, Elisa M., et al.
Publicado: (2016)

The Falciform Ligament for Mesenteric and Portal Vein Reconstruction in Local Advanced Pancreatic Tumor: A Surgical Guide and Single-Center Experience
por: Malinka, T., et al.
Publicado: (2018)

Carbohydrate Antigen Microarrays
por: Wang, Denong
Publicado: (2011)

Clinical characteristics and outcomes in carbohydrate antigen 19-9 negative pancreatic cancer
por: Balaban, Daniel Vasile, et al.
Publicado: (2022)

CT and MRI Findings of Autoimmune Polymorph Bifocal Pancreatitis Mimicking Pancreatic Adenocarcinoma: A Case Report and Review of the Literature
por: Rotzinger, Roman, et al.
Publicado: (2015)

Carcinoembryonic antigen, carbohydrate antigen 199 and carbohydrate antigen 724 in gastric cancer and their relationship with clinical prognosis
por: Wang, Ran, et al.
Publicado: (2023)

High SIRT1 expression is a negative prognosticator in pancreatic ductal adenocarcinoma
por: Stenzinger, Albrecht, et al.
Publicado: (2013)

Low-level viremia in patients undergoing antiviral therapy: Does it indicate time for a change?
por: Kim, Jung Hee, et al.
Publicado: (2020)

Postoperative Carcinoembryonic Antigen as a Complementary Tumor Marker of Carbohydrate Antigen 19-9 in Pancreatic Ductal Adenocarcinoma
por: Kim, Jaihwan, et al.
Publicado: (2015)

The Impact of Simultaneous Liver Resection for Occult Liver Metastases of Pancreatic Adenocarcinoma
por: Klein, F., et al.
Publicado: (2012)

CARBOHYDRATES ADSORBED ON COLLOIDS AS ANTIGENS
por: Zozaya, José
Publicado: (1932)

Emerging Role of Targeted Therapy in Metastatic Pancreatic Adenocarcinoma
por: Huffman, Brandon M., et al.
Publicado: (2022)

Are targeted therapies or immunotherapies effective in metastatic pancreatic adenocarcinoma?
por: Rémond, M.S., et al.
Publicado: (2022)

Diagnostic and economic value of carcinoembryonic antigen, carbohydrate antigen 19-9, and carbohydrate antigen 72-4 in gastrointestinal cancers
por: Liu, Hai-Ning, et al.
Publicado: (2023)

Prognostic Factors for Long-Term Survival in Patients with Ampullary Carcinoma: The Results of a 15-Year Observation Period after Pancreaticoduodenectomy
por: Klein, Fritz, et al.
Publicado: (2014)

Bovine Serum Albumin-Glutaraldehyde Sealed Fish-Mouth Closure of the Pancreatic Remnant during Distal Pancreatectomy
por: Klein, Fritz, et al.
Publicado: (2017)

Systemic therapy in metastatic pancreatic adenocarcinoma: current practice and perspectives
por: Lellouche, Lisa, et al.
Publicado: (2021)

Two-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy
por: Klein, Fritz, et al.
Publicado: (2016)

Role of carbohydrate antigen 19-9, carcinoembryonic antigen, and carbohydrate antigen 125 as the predictors of resectability and survival in the patients of Carcinoma Gall Bladder
por: Agrawal, Saumya, et al.
Publicado: (2020)

Implementation of Robotic Assistance in Pancreatic Surgery: Experiences from the First 101 Consecutive Cases
por: Timmermann, Lea, et al.
Publicado: (2021)

Correction: Felsenstein M. et al. Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies? J. Clin. Med. 2022, 11, 2367
por: Felsenstein, Matthäus, et al.
Publicado: (2023)

Explorative analysis of a score predicting the therapy response of patients with metastatic, castration resistant prostate cancer undergoing radioligand therapy with (177)Lu-labeled prostate-specific membrane antigen
por: Huang, Kai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_71f6s1k8e8e3kh7dhb04ha0kd6